[THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
D000614:Aminocaproates; D015119:Aminocaproic Acid; D007611:Aprotinin; D001565:Benzoates; D004791:Enzyme Inhibitors; D005340:Fibrinogen; D005342:Fibrinolysis; D007610:Kallikreins; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D013916:Thrombelastography; D013917:Thrombin; D014357:Trypsin
D000614:Aminocaproates; D001565:Benzoates; D004791:Enzyme Inhibitors; D005340:Fibrinogen; D007611:Aprotinin; D007610:Kallikreins; D014357:Trypsin; D013917:Thrombin; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; BENZOATES; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FIBRINOLYSIS; KALLIKREIN; KALLIKREIN-TRYPSIN INACTIVATOR; PHARMACOLOGY; RABBITS; THROMBOELASTOGRAPHY; TRYPSIN
DIE KOMBINATIONSWIRKUNG VON FIBRINOLYSEHEMMSTOFFEN.